Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an Observational Study

The role of interleukin-18 in the metabolic syndrome

(2010) Marius Trøseid et al.   Cardiovascular Diabetology

Arterial stiffness is independently associated with interleukin-18 and components of the metabolic syndrome

(2009) Marius Trøseid et al.   ATHEROSCLEROSIS

Circulating IL-18 and the risk of type 2 diabetes in women

(2009) M. F. Hivert et al.   DIABETOLOGIA

The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease

(2009) Simon W Rabkin   Nature Reviews Cardiology

IL-18 gene polymorphism and metabolic syndrome

(2009) I. Presta et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

GENDER DIFFERENCE IN GRANULOCYTE DYNAMICS AND APOPTOSIS AND THE ROLE OF IL-18 DURING ENDOTOXIN-INDUCED SYSTEMIC INFLAMMATION

(2009) Michiko Aoyama et al.   SHOCK

Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome: Synergistic effect of inflammation and hyperglycemia

(2008) M. Troseid et al.   DIABETES CARE

Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome

(2008) Christine Espinola-Klein et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Interleukin-18 promoter polymorphism associates with the occurrence of sudden cardiac death among Caucasian males: The Helsinki Sudden Death Study

(2007) Jussi A. Hernesniemi et al.   ATHEROSCLEROSIS